Pericarditis in a Case of Early Daunorubicin Cardiomyopathy

  1. DAVID T. HARRISON, M.D.; and
  2. LEE A. SANDERS, M.D., PH.D.
  1. Departments of Medicine and Pathology
    University of Washington School of Medicine
    Seattle, WA 98195

    Excerpt

    The anthracycline antibiotics, daunorubicin and adriamycin, may both produce serious cardiac toxicity (1, 2). Cardiomyopathy appearing within months of a cumulative

    Figure
    View larger version:

      dose of daunorubicin exceeding 750 mg/m2 body surface was initially described. The cardinal features were cardiomegaly with biventricular failure and reduced electrocardiogram (ECG) voltage variably responsive to medical therapy. Subsequently the syndrome was observed after smaller doses, and fulminant cardiovascular collapse was described. We witnessed such a case 6 days after a total daunorubicin course of 210 mg/m2 body surface where pericarditis heralded the cardiac toxicity.

      A 41-year-old woman was referred for treatment of recently

      This 100-word excerpt has been provided in the absence of an abstract.

      « Previous | Next Article »Table of Contents